These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9654967)

  • 1. [Pulmonary fibrosis and systemic sclerosis].
    Georgescu M; Roşca D
    Pneumoftiziologia; 1997; 46(4):267-83. PubMed ID: 9654967
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pulmonary involvement in systemic sclerosis].
    Ioanăş M
    Pneumologia; 2002; 51(3):230-3. PubMed ID: 12602096
    [No Abstract]   [Full Text] [Related]  

  • 3. Decrease in DL,CO in systemic sclerosis correlates with acceleration of DTPA clearance.
    Diot E; Giraudeau B; Maillot F; Diot P
    Eur Respir J; 1999 Sep; 14(3):728-9. PubMed ID: 10543302
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomarkers in systemic sclerosis.
    Castro SV; Jimenez SA
    Biomark Med; 2010 Feb; 4(1):133-47. PubMed ID: 20387310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transforming growth factor-beta and its receptors in scleroderma].
    QIAN H; ZHENG M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
    Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
    Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prolyl 4-hydroxylase inhibitor on fibroblast collagen production in vitro: an approach to the treatment of systemic sclerosis.
    Kawaguchi Y; Harigai M; Kitani A; Suzuki K; Kawakami M; Ishizuka T; Hidaka T; Hara M; Kawagoe M; Nakamura H
    J Rheumatol; 1992 Nov; 19(11):1710-5. PubMed ID: 1337110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroderma and related conditions.
    Mitchell H; Bolster MB; LeRoy EC
    Med Clin North Am; 1997 Jan; 81(1):129-49. PubMed ID: 9012758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung involvement in systemic sclerosis sine scleroderma treated by plasma exchange.
    Ferri C; Bernini L; Gremignai G; Latorraca A; Fazzi P; Tavon A; Solfanelli S; Bombardieri S
    Int J Artif Organs; 1992 Jul; 15(7):426-31. PubMed ID: 1516994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic sclerosis sine scleroderma presenting as pulmonary intersticial fibrosis.
    Vañó Sanchis D; Arranz Garcia G; Yglesias PJ
    Clin Rheumatol; 2006 May; 25(3):382-3. PubMed ID: 16211337
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
    Dooley A; Shi-Wen X; Aden N; Tranah T; Desai N; Denton CP; Abraham DJ; Bruckdorfer R
    Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
    Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis.
    Kuhn C; McDonald JA
    Am J Pathol; 1991 May; 138(5):1257-65. PubMed ID: 2024710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma?
    Brinckmann J; Kim S; Wu J; Reinhardt DP; Batmunkh C; Metzen E; Notbohm H; Bank RA; Krieg T; Hunzelmann N
    Matrix Biol; 2005 Oct; 24(7):459-68. PubMed ID: 16139999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomedical research. More than skin deep.
    Cahoon L
    Science; 2008 Oct; 322(5902):667-9. PubMed ID: 18974325
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-beta.
    Xu WD; Leroy EC; Smith EA
    J Rheumatol; 1991 Feb; 18(2):241-6. PubMed ID: 2023218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dermatological aspects on systemic sclerosis].
    Ishikawa O; Akimoto S
    Ryumachi; 2000 Feb; 40(1):39-47. PubMed ID: 10783665
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of leukotrienes in alveolitis associated with scleroderma.
    Simms RW; Korn JH
    Arthritis Rheum; 2003 Jun; 48(6):1478-80. PubMed ID: 12794812
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pulmonary involvement in systemic scleroderma].
    Guillevin L; Mouthon L
    Bull Acad Natl Med; 2011 Jan; 195(1):79-90; discussion 90-2. PubMed ID: 22039705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.